Ekocorp Past Earnings Performance

Past criteria checks 0/6

There is insufficient data on Ekocorp's performance over the last few years.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Healthcare Industry Growth13.4%
Revenue growth raten/a
Return on equityn/a
Net Marginn/a
Last Earnings Update30 Sep 2021

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Ekocorp makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NGSE:EKOCORP Revenue, expenses and earnings (NGN Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 21883-4483710
30 Jun 21932-3733660
31 Mar 21924-3743630
31 Dec 20981-3483880
30 Sep 201,030-2903490
30 Jun 201,101-3153550
31 Mar 201,195-3133650
31 Dec 191,251-2923620
30 Sep 191,319-3374110
30 Jun 191,349-3314200
31 Mar 191,438-3084430
31 Dec 181,473-3284470
30 Sep 181,472-1,5851,5240
30 Jun 181,522-1,4231,4770
31 Mar 181,482-1,3241,4180
31 Dec 171,485-1,2121,3820
30 Sep 171,4411331880
30 Jun 171,4351402050
31 Mar 171,3991142360
31 Dec 161,352802710
31 Dec 151,3711471790
31 Dec 141,3041571670
30 Sep 141,3082041740
31 Mar 141,2431741680
31 Dec 131,2151531640
30 Sep 131,1761581430

Quality Earnings: Insufficient data to determine if EKOCORP has high quality earnings.

Growing Profit Margin: Insufficient data to determine if EKOCORP's profit margins have improved over the past year.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if EKOCORP's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Insufficient data to compare EKOCORP's past year earnings growth to its 5-year average.

Earnings vs Industry: Insufficient data to determine if EKOCORP's earnings growth over the past year exceeded the Healthcare industry average.


Return on Equity

High ROE: EKOCORP has a negative Return on Equity (0%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.